Pacific Center for Financial Services’s Theravance Biopharma TBPH Stock Holding History

Pacific Center for Financial Services’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$969	Hold	57	–	–	﹤0.01%	455
2026 Q1	$926	Hold	57	–	–	﹤0.01%	470
2025 Q4	$833	Hold	57	–	–	﹤0.01%	438
2025 Q3	$833	Hold	57	–	–	﹤0.01%	438
2025 Q2	$629	Hold	57	–	–	﹤0.01%	433
2025 Q1	$510	Hold	57	–	–	﹤0.01%	442
2024 Q4	$537	Hold	57	–	–	﹤0.01%	443
2024 Q3	$460	Hold	57	–	–	﹤0.01%	440
2024 Q2	$484	Hold	57	–	–	﹤0.01%	437
2024 Q1	$512	Hold	57	–	–	﹤0.01%	440
2023 Q4	$641	Hold	57	–	–	﹤0.01%	370
2023 Q3	$492	Hold	57	–	–	﹤0.01%	388
2023 Q2	$590	Hold	57	–	–	﹤0.01%	378
2023 Q1	$619	Buy	+57	New	+$603	﹤0.01%	377
2022 Q3	$1K	Hold	57	–	–	﹤0.01%	385
2022 Q2	$1K	Hold	57	–	–	﹤0.01%	381
2022 Q1	$1K	Hold	57	–	–	﹤0.01%	366
2021 Q4	$1K	Hold	57	–	–	﹤0.01%	375
2021 Q3	$0	Hold	57	–	–	﹤0.01%	413
2021 Q2	$1K	Hold	57	–	–	﹤0.01%	340
2021 Q1	$1K	Hold	57	–	–	﹤0.01%	329
2020 Q4	$1K	Hold	57	–	–	﹤0.01%	318
2020 Q3	$1K	Buy	+57	New	+$1.07K	﹤0.01%	297
2020 Q2	–	Sell	-57	Closed	-$1K	–	318
2020 Q1	$1K	Buy	+57	New	+$1.43K	﹤0.01%	281

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

ICM

Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Pacific Center for Financial Services's TBPH Position: Q2 2026 in Review

Pacific Center for Financial Services held its Theravance Biopharma (TBPH) position steady in Q2 2026 at 57 shares worth $969. The position accounts for ﹤0.01% of the portfolio, ranked #455.

Pacific Center for Financial Services first reported a position in TBPH in Q1 2020 and has held it in 24 quarters since. The position peaked at $1K in Q3 2022. 181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

Pacific Center for Financial Services held 57 shares of Theravance Biopharma worth $969 as of Q2 2026.
Pacific Center for Financial Services left its Theravance Biopharma share count unchanged in Q2 2026.
Theravance Biopharma made up ﹤0.01% of Pacific Center for Financial Services's portfolio in Q2 2026, its #455 holding.
Pacific Center for Financial Services first reported a position in Theravance Biopharma in Q1 2020 and has held it in 24 quarters since.
Pacific Center for Financial Services's Theravance Biopharma position peaked at $1K in Q3 2022.
181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.